Literature DB >> 11335737

Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates.

M Vento1, M Asensi, J Sastre, F García-Sala, F V Pallardó, J Viña.   

Abstract

BACKGROUND: Traditionally, asphyxiated newborn infants have been ventilated using 100% oxygen. However, a recent multinational trial has shown that the use of room air was just as efficient as pure oxygen in securing the survival of severely asphyxiated newborn infants. Oxidative stress markers in moderately asphyxiated term newborn infants resuscitated with either 100% oxygen or room air have been studied for the first time in this work.
METHODS: Eligible term neonates with perinatal asphyxia were randomly resuscitated with either room air or 100% oxygen. The clinical parameters recorded were those of the Apgar score at 1, 5, and 10 minutes, the time of onset of the first cry, and the time of onset of the sustained pattern of respiration. In addition, reduced and oxidized glutathione concentrations and antioxidant enzyme activities (superoxide dismutase, catalase, and glutathione peroxidase) were determined in blood from the umbilical artery during delivery and in peripheral blood at 72 hours and at 4 weeks' postnatal age.
RESULTS: Our results show that the room-air resuscitated (RAR) group needed significantly less time to first cry than the group resuscitated with 100% oxygen (1.2 +/- 0.6 minutes vs 1.7 +/- 0.5). Moreover, the RAR group needed less time undergoing ventilation to achieve a sustained respiratory pattern than the group resuscitated with pure oxygen (4.6 +/- 0.7 vs 7.5 +/- 1.8 minutes). The reduced-to-oxidized-glutathione ratio, which is an accurate index of oxidative stress, of the RAR group (53 +/- 9) at 28 days of postnatal life showed no differences with the control nonasphyxiated group (50 +/- 12). However, the reduced-to-oxidized-glutathione ratio of the 100% oxygen-resuscitated group (OxR) (15 +/- 5) was significantly lower and revealed protracted oxidative stress. Furthermore, the activities of superoxide dismutase and catalase in erythrocytes were 69% and 78% higher, respectively, in the OxR group than in the control group at 28 days of postnatal life. Thus, this shows that these antioxidant enzymes, although higher than in controls, could not cope with the ongoing generation of free radicals in the OxR group. However, there were no differences in antioxidant enzyme activities between the RAR group and the control group at this stage.
CONCLUSIONS: There are no apparent clinical disadvantages in using room air for ventilation of asphyxiated neonates rather than 100% oxygen. Furthermore, RAR infants recover more quickly as assessed by Apgar scores, time to the first cry, and the sustained pattern of respiration. In addition, neonates resuscitated with 100% oxygen exhibit biochemical findings reflecting prolonged oxidative stress present even after 4 weeks of postnatal life, which do not appear in the RAR group. Thus, the current accepted recommendations for using 100% oxygen in the resuscitation of asphyxiated newborn infants should be further discussed and investigated.

Entities:  

Mesh:

Year:  2001        PMID: 11335737     DOI: 10.1542/peds.107.4.642

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  54 in total

Review 1.  Pinching, electrocution, ravens' beaks, and positive pressure ventilation: a brief history of neonatal resuscitation.

Authors:  C P F O'Donnell; A T Gibson; P G Davis
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-09       Impact factor: 5.747

2.  Effect of resuscitation with 21% oxygen and 100% oxygen on NMDA receptor binding characteristics following asphyxia in newborn piglets.

Authors:  David Joseph Hoffman; Eric Lombardini; Om Prakash Mishra; Maria Delivoria-Papadopoulos
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

3.  Pulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitation.

Authors:  Satyan Lakshminrusimha; James A Russell; Robin H Steinhorn; Rita M Ryan; Sylvia F Gugino; Frederick C Morin; Daniel D Swartz; Vasanth H Kumar
Journal:  Pediatr Res       Date:  2005-12-02       Impact factor: 3.756

Review 4.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 5.  [Resuscitation of newborn infants].

Authors:  T M Berger; S Pilgrim
Journal:  Anaesthesist       Date:  2009-01       Impact factor: 1.041

6.  Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells.

Authors:  Kathryn N Farrow; Beezly S Groh; Paul T Schumacker; Satyan Lakshminrusimha; Lyubov Czech; Sylvia F Gugino; James A Russell; Robin H Steinhorn
Journal:  Circ Res       Date:  2007-11-08       Impact factor: 17.367

7.  Effect of Oxygen vs Room Air on Intrauterine Fetal Resuscitation: A Randomized Noninferiority Clinical Trial.

Authors:  Nandini Raghuraman; Leping Wan; Lorene A Temming; Candice Woolfolk; George A Macones; Methodius G Tuuli; Alison G Cahill
Journal:  JAMA Pediatr       Date:  2018-09-01       Impact factor: 16.193

8.  The association of early blood oxygenation with child development in preterm infants with acute respiratory disorders.

Authors:  Karen E Smith; Susan Keeney; Lifang Zhang; J Regino Perez-Polo; David K Rassin
Journal:  Int J Dev Neurosci       Date:  2007-09-29       Impact factor: 2.457

9.  A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity.

Authors:  Kenneth W Wright; David Sami; Lisa Thompson; Rangasamy Ramanathan; Roy Joseph; Sonal Farzavandi
Journal:  Trans Am Ophthalmol Soc       Date:  2006

10.  Resuscitation with 100% O(2) does not protect the myocardium in hypoxic newborn piglets.

Authors:  W B Børke; B H Munkeby; L Mørkrid; E Thaulow; O D Saugstad
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.